Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
Best Wellness Tracker Keep You On target - 2Yasser Abu Shabab's killing raises questions about Israel's militia strategy in Gaza
- 3Israel approves death penalty law for Palestinians convicted of attacks
- 4Supercharge Your Remote Work Arrangement with These Game-Changing Instruments
- 5Exhaustive Experiences into Prudent Senior Living in the UK
- Vote in favor of the Top Vegetable for Senior
- I was about to film a movie with Glen Powell when my hair started falling out in clumps. Alopecia has made me unrecognizable as an actor.
- Decrease in Home Buy Credits and Home loan Renegotiating Rates: An Outline of Latest things
- Creative Style: 10 Architects Reclassifying the Business
- Iranian-linked drone attack kills Kurdish couple in northern Iraq
- Travels to Dream Objections in Europe
- 'Crammed into a cell with vermin at New Year'
- 1st-ever disease gene fix, Alzheimer's blood test: 7 medical breakthroughs in 2025
- Careful Connections: Building Association and Trust
